Fungal infections are on the rise globally. According to a study by the Manchester Fungal Infection Group, in 2022, ...

RNA-based therapeutics are gaining traction due to advancements in delivery technologies, despite historical challenges with ...

In the microscopic world of bacteria, gene transfer is a powerful mechanism that can alter cellular function, drive ...

Korro Bio's OPERA platform offers precise RNA editing for genetic diseases like Alpha-1 antitrypsin deficiency. Learn more on ...

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top ...

BMO Capital Markets analysts said the results potentially position lepodisiran as “one of the most durable assets in ...

Bioluminescent luciferase enzymes have historically been too dim to use as probes in living tissue. But recent advances have ...

When exposed to antibiotics, approximately one out of every 10 8 -10 9 bacteria develops resistance due to spontaneous ...

A single dose of an experimental drug has been found to reduce the risk of genetic heart disease by at least 94 per cent. Lepodisiran, developed by Eli Lilly, has shown promising results in reducing ...

Scientists at the UCLA Health Jonsson Comprehensive Cancer Center and the University of Toronto have revealed how a tiny ...

Researchers at Martin Luther University have developed groundbreaking RNA-based agents that offer high levels of protection ...